Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products
- DOI
- 10.3389/fimmu.2025.1730346
- Published
- 2025-12-08
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2025.1730346,
title = {Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products},
author = {Aimee E. Mattei and Brian J. Roberts and Sandra Lelias and Shah Miah and Kristina E. Howard and James L. Weaver and Daniela Verthelyi and Eric S. Pang and Katie Edwards and Anne S. De Groot},
year = {2025},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2025.1730346},
url = {https://doi.org/10.3389/fimmu.2025.1730346}
}RIS
TY - JOUR TI - Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products AU - Aimee E. Mattei AU - Brian J. Roberts AU - Sandra Lelias AU - Shah Miah AU - Kristina E. Howard AU - James L. Weaver AU - Daniela Verthelyi AU - Eric S. Pang AU - Katie Edwards AU - Anne S. De Groot PY - 2025 JO - Frontiers in Immunology DO - 10.3389/fimmu.2025.1730346 UR - https://doi.org/10.3389/fimmu.2025.1730346 ER -
APA
Mattei, A. E., Roberts, B. J., Lelias, S., Miah, S., Howard, K. E., Weaver, J. L., Verthelyi, D., Pang, E. S., Edwards, K., & Groot, A. S. D. (2025). Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1730346
Source records
- crossref · retrieved 2026-09-27T05:59:09.249Z